European Medical Solutions (STU:AS00) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
45 GF Score
Price €4.74
GF Value €8.10
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Research & Development?

European Medical Solutions STU:AS00 +0.42% 45 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 45/100 and a GF Value™ of €8.10. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. European Medical Solutions's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

European Medical Solutions  (STU:AS00) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

European Medical Solutions Research & Development Related Terms

European Medical Solutions Research & Development Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions Research & Development Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.04 0.00 0.00 0.00

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:AS00
45GF Score
European Medical Solutions STU:AS00
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
European Medical Solutions (STU:AS00) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on European Medical Solutions and its competitors.
Is European Medical Solutions' Research & Development too high?
European Medical Solutions' current Research & Development is €0.00 Mil. Overall, European Medical Solutions has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Research & Development compare to VRTX and REGN?
European Medical Solutions' Research & Development of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €8.10, compared to a current price of €4.74 — trading 41.5% below its estimated fair value. The current Research & Development is €0.00 Mil. European Medical Solutions' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.74 is trading 41.5% below its estimated GF Value™ of €8.10.

Key valuation signals for STU:AS00:

  • Research & Development: €0.00 Mil
  • GF Value™: €8.10 vs. price of €4.74 (41.5% below fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
45GF Score

Get the complete analysis for STU:AS00

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.74
Price
€8.10
GF Value